42-year-old man was admitted to hospital with worsening dyspnea. At the age of 18, he underwent annuloplasty of the systemic AV valve for severe valvular regurgitation related to CCTGA at another hospital and did not have any problems on follow-up until age 33 when he visited hospital with paroxysmal nocturnal dyspnea. Because the systemic AV valve regurgitation had recurred to a severe degree and systemic ventricular contraction had decreased, he underwent systemic AV valve replacement and annuloplasty of the pulmonary AV valve. At age 39, atrial fibrillation with a rapid heart rate developed and could not be controlled with medications, so the His-bundle was cryoablated to block AV conduction and a permanent rate-adaptive pacemaker inserted intravenously. Although he was controlled in all pacemaker rhythm without tachycardia, his systemic ventricular function decreased and he was in New York Heart Association (NYHA) functional class 4 even after receiving digitalis, diuretics, angiotensin-converting enzyme inhibitor (ACEI) and other oral inotropic agents.
42-year-old man was admitted to hospital with worsening dyspnea. At the age of 18, he underwent annuloplasty of the systemic AV valve for severe valvular regurgitation related to CCTGA at another hospital and did not have any problems on follow-up until age 33 when he visited hospital with paroxysmal nocturnal dyspnea. Because the systemic AV valve regurgitation had recurred to a severe degree and systemic ventricular contraction had decreased, he underwent systemic AV valve replacement and annuloplasty of the pulmonary AV valve. At age 39, atrial fibrillation with a rapid heart rate developed and could not be controlled with medications, so the His-bundle was cryoablated to block AV conduction and a permanent rate-adaptive pacemaker inserted intravenously. Although he was controlled in all pacemaker rhythm without tachycardia, his systemic ventricular function decreased and he was in New York Heart Association (NYHA) functional class 4 even after receiving digitalis, diuretics, angiotensin-converting enzyme inhibitor (ACEI) and other oral inotropic agents.
His height was 185 cm and body weight was 75 kg. His blood pressure was 116/60 mmHg and the pulse rate was 60 beats/min and regular. Auscultation showed no significant murmur. Electrocardiograms revealed all pacemaker rhythm (VVI). Chest X-rays showed a cardiothoracic ratio of 58% and systemic atrial and ventricular enlargement. Echocardiography revealed enlargement of the systemic atrium and ventricle, and reduction of the systemic ventricular systolic function (the left atrial dimension was 4.7 cm, the end-diastolic dimension of the systemic ventricle was 8.6 cm and the fractional shortening was 14%) ( Table 1 , Fig 1) . Pulmonary wedge pressure and right-side pressures were elevated ( Table 2 ). The systemic ventriculogram showed diffused hypokinesis, but myocardial perfusion imaging using technetium-99m tetrofosmin indicated a severe perfusion defect in the lateral wall and the apex at rest.
Because his symptoms could not be relieved by medical treatment, he was transferred to Shonan Kamakura General Hospital to undergo partial systemic ventriculectomy in February 1998. Under cardiopulmonary bypass (CPB) with heart beating and without aortic cross-clamping, the systemic ventricle was incised laterally from the apex to the base. There was neither mitral apparatus nor recognizable papillary muscle because of the previous valve replacement. Much of the anterolateral wall that was thin and akinetic on intraoperative palpation, and which corresponded to the defect on perfusion imaging, was excised in a tear-drop shape (7 cm wide and 12 cm long, 66 g in weight). Closure of the ventricle was done in 2 layers. The duration of CPB was 73 min and ventricular function recovered well without mechanical support. The resected myocardium had severe interstitial fibrosis (28.5%) and mild degeneration and hypertrophy of the myocardial cells.
On echocardiography, the end-diastolic dimension of the systemic ventricle decreased to 5.7 cm, but the ejection fraction (EF) had not changed at 1 month after the operation (Table 1, Fig 1) . A thickened pericardium and pericardial effusion were noted behind the systemic ventricle after the operation. On contrast-enhanced electron-beam computed tomograms, the end-diastolic volume of the systemic ventricle was decreased from 213 ml to 180 ml after systemic ventriculectomy, but stroke volume was not reduced (38 ml to 41 ml) and the EF increased from 18% to 23% (Table 2) . On cardiac catheterization performed 2 months after the operation, pulmonary wedge pressure and right-side pressures were decreased, but cardiac output (CO) was somewhat reduced (Table 2 ). Nine months after the operation, CO returned to the preoperative level (Table 2 ) and the EF had increased from 15% to 38% on radionuclide angiography (Table 3) , but pulmonary wedge pressure and rightside pressures were re-elevated ( Table 2) .
The patient's symptoms had clearly improved after the 
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Discussion
In CCTGA, the dysfunction of the systemic ventricle occurs with increasing frequency in older patients; [2] [3] [4] Graham et al 4 reported long-term outcomes of 182 patients with CCTGA, which indicated that by age 45, 56% of the patients with associated lesions had moderate or severe systemic ventricular dysfunction, and 32% of the patients without associated lesions had this complication. They also reported that the strongest risk factors for clinical congestive heart failure and systemic ventricular dysfunction were systemic valve surgery, systemic AV valve regurgitation, significant arrhythmia, history of any open heart surgery, and pacemaker therapy. However, it remains speculative whether systemic AV valve regurgitation is a causative or a secondary complication of systemic ventricular dysfunction. [3] [4] [5] The present patient had all these risk factors and when he underwent systemic AV valve replacement for the severe valve regurgitation, his systemic ventricular contraction had already decreased (Table 3) . Open heart surgery (particularly systemic AV valve surgery) is associated with the progression of systemic ventricular dysfunction and probably results from an increase in afterload and/or difficulty in myocardial protection during surgery. 4 The further reduction of the systemic ventricular EF after systemic AV valve replacement in this patient is possibly the result of increased afterload related to the correction of AV valve regurgitation (Table 3) . Heart block and ventricular pacing can worsen systemic ventricular dysfunction because they can result in discordant ventricular contraction. 4 It is considered that long-term exposure to systemic pressure is an etiology of systemic ventricular dysfunction in patients with CCTGA. 2 Hornung et al detected myocardial perfusion defects on radioisotope images in 5 patients with CCTGA who had not undergone surgery. 6 Fixed defects that suggested myocardial infarction were seen in all 5 and reversible myocardial ischemia was present in 4 of them. Irreversible defects were mostly associated with the impairment of wall motion, and the EF was decreased in 4 patients. It is now clear that the coronary flow supplied by only the right coronary artery system to a markedly dilated systemic ventricle is inadequate for myocardial perfusion.
Batista recently introduced a new procedure for patients with a very dilated and poorly contracting left ventricle resulting from any etiology, in which a large wedge of left ventricular myocardium is removed. 7 The principle underlying this partial left ventriculectomy is related to LaPlace's law; that is, to reduce the wall tension by shortening the diameter of the left ventricle. Batista reported 120 surgical patients with 30-day mortality rates of 22% and 2-year survival rates of 55%. Most of the surviving patients improved from NYHA functional class 4 to either class 1 (57%) or 2 (33%). In Japan, cardiac transplantation has recently begun, but there is a shortage of donors, so since 1996 partial left ventriculectomy has been performed as a treatment for patients with end-stage dilated cardiomyopathy in Japan. 8 Starling et al indicated that although stroke volume is reduced after ventriculectomy, the heart rate increases, and the end result is somewhat increased CO. However, they suggested that this procedure gave only temporary improvement in clinical compensation because the CO fell back to baseline levels after 3-12 months in spite of the increase of stroke volume. 9 The current indications and efficacy of partial left ventriculectomy for advanced heart failure in patients with dilated cardiomyopathy are controversial. 9, 10 Because the systemic ventricle was markedly dilated in the present patient, and the lateral segment had a myocardial perfusion defect, we considered that systolic function could be improved by reducing the volume of the systemic ventricle, particularly by removing the fibrous segment as in aneurysmectomy. Recent reports indicate that mitral valve surgery can rescue patients with heart failure who have a dilated and poorly contracting left ventricle accompanied by moderate to severe mitral regurgitation, 10 but we considered that mitral replacement would not provide relief for this patient because he had already undergone that treatment 9 years before. After operation, the pulmonary artery and pulmonary capillary pressures gradually rose to the preoperative level. Although there was no sign that the systemic ventricle had dilated again, its systolic function had clearly deteriorated after the partial systemic ventriculectomy and we could not clarify why the EF obtained with echocardiography conflicted with the value obtained from catheterization. These changes may relate to systemic ventricular dysfunction that persists after the operation, restrictive physiology because of volume reduction and constrictive physiology related to the three pericardiotomies. Finally, although we could not conclude how the patient's symptoms had been relieved, we consider that partial systemic ventriculectomy can be effective, but not curative, for patients with CCTGA and heart failure. 
